Expertise in
19
conditions

Dr. Arta M. Monjazeb

Radiology | Radiation Oncology
Mercy Cancer Center, 3850 G St, 
Merced, CA 
Accepting New Patients
Offers Telehealth
Referral may be required
Before you request
Expertise in
19
conditions
Mercy Cancer Center, 3850 G St, 
Merced, CA 

Overview

Arta Monjazeb is a Radiologist and a Radiation Oncologist practicing medicine in Merced, California.

Dr. Monjazeb is highly rated in 19 conditions, according to our data. His clinical expertise encompasses Adult Soft Tissue Sarcoma, Bone Tumor, Squamous Cell Carcinoma of the Anal Canal (SCAC), and Anal Cancer.

Dr. Monjazeb is board certified in Radiology Radiation Oncology. He is actively involved in clinical research, co-authoring 111 peer reviewed articles and participating in 5 clinical trials. Dr. Monjazeb is currently accepting new patients.

Specialties

Radiology
Radiation Oncology

Licenses

Radiology in CA

Board Certifications

Radiology Radiation Oncology

Hospital Affiliations

Marshall Medical Center
University Of California Davis Medical Center

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 2 Less Insurance Carriers -

Locations

Arta M. Monjazeb, MD Private Practice
Mercy Cancer Center, 3850 G St, Merced, CA 95340

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Phase 2 Study of MEDI4736 (Durvalumab) and Tremelimumab Alone or in Combination With High or Low-Dose Radiation in Metastatic Colorectal and NSCLC
A Phase 2 Study of MEDI4736 (Durvalumab) and Tremelimumab Alone or in Combination With High or Low-Dose Radiation in Metastatic Colorectal and NSCLC
Enrollment Status: Active_not_recruiting
Publish Date: July 31, 2026
Intervention Type: Biological, Radiation
Study Drugs: Durvalumab, Tremelimumab
Study Phase: Phase 2
UCDCC#272: A Phase I/II Study of Intralesional IL-2, Hypofractionated Radiotherapy, and Pembrolizumab in Patients Refractory to Standard-of-Care PD-1/PD-L1 Checkpoint Blockade
UCDCC#272: A Phase I/II Study of Intralesional IL-2, Hypofractionated Radiotherapy, and Pembrolizumab in Patients Refractory to Standard-of-Care PD-1/PD-L1 Checkpoint Blockade
Enrollment Status: Active_not_recruiting
Publish Date: January 29, 2026
Intervention Type: Drug, Radiation
Study Drugs: IL-2, Pembrolizumab
Study Phase: Phase 1/Phase 2
A Phase II Clinical Trial Platform of Sensitization Utilizing Total Neoadjuvant Therapy (TNT) in Rectal Cancer
A Phase II Clinical Trial Platform of Sensitization Utilizing Total Neoadjuvant Therapy (TNT) in Rectal Cancer
Enrollment Status: Completed
Publish Date: December 04, 2025
Intervention Type: Drug, Radiation, Biological
Study Phase: Phase 2
UCDCC#271: A Phase I/II Trial of Epacadostat (Indolamine 2,3 Dioxygenase Inhibitor), Intralesional SD101 (Toll-receptor 9 Agonist), and Radiotherapy in Patients With Advanced Solid Tumors and Lymphoma
UCDCC#271: A Phase I/II Trial of Epacadostat (Indolamine 2,3 Dioxygenase Inhibitor), Intralesional SD101 (Toll-receptor 9 Agonist), and Radiotherapy in Patients With Advanced Solid Tumors and Lymphoma
Enrollment Status: Completed
Publish Date: February 01, 2022
Intervention Type: Radiation, Drug
Study Drugs: Epacadostat, SD-101
Study Phase: Phase 1/Phase 2
UCDCC#269: A Pilot Study of Interlesional IL-2 and Hypofractionated Radiotherapy in Patients With Metastatic Non-small Cell Lung Cancer Who Are Refractory to PD 1 / PD L1 Blockade.
UCDCC#269: A Pilot Study of Interlesional IL-2 and Hypofractionated Radiotherapy in Patients With Metastatic Non-small Cell Lung Cancer Who Are Refractory to PD 1 / PD L1 Blockade.
Enrollment Status: Completed
Publish Date: April 07, 2020
Intervention Type: Radiation, Drug
Study Phase: Early Phase 1
View 4 Less Clinical Trials

111 Total Publications

A phase II multi-institutional single arm trial evaluating TG4010 vaccine plus nivolumab in non-small cell lung cancer.
A phase II multi-institutional single arm trial evaluating TG4010 vaccine plus nivolumab in non-small cell lung cancer.
Journal: Oncoimmunology
Published: September 02, 2026
Similar Doctors
Expertise in
37
conditions
Dr. Ruben C. Fragoso
Radiology | Radiation Oncology
Expertise in
37
conditions
Dr. Ruben C. Fragoso
Radiology | Radiation Oncology
Referral may be required
Before you request

Mercy Cancer Center

3850 G St, 
Merced, CA 
 (2.5 miles away)
209-564-3600
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Ruben Fragoso is a Radiologist and a Radiation Oncologist practicing medicine in Merced, California. Dr. Fragoso is highly rated in 37 conditions, according to our data. His clinical expertise encompasses Meningioma, Astrocytoma, Radiation Induced Meningioma, and Glioblastoma. Dr. Fragoso is board certified in Radiology Radiation Oncology. Dr. Fragoso is currently accepting new patients.

Expertise in
12
conditions
Dr. Megan E. Daly
Radiation Oncology
Expertise in
12
conditions
Dr. Megan E. Daly
Radiation Oncology
Referral may be required
Before you request

Megan E. Daly, MD Private Practice

3850 G St, 
Merced, CA 
 (2.5 miles away)
209-564-3601
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Dr. Megan E. Daly is a board-certified UCI Health radiation oncologist.She earned her medical degree and completed a residency in radiation oncology at Stanford University School of Medicine. Dr. Daly is highly rated in 12 conditions, according to our data. Her clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), Gastrostomy, and Microvascular Decompression. Dr. Daly is board certified in American Board Of Radiology - Radiation Oncology and Radiology Radiation Oncology. Dr. Daly is currently accepting new patients.

Expertise in
5
conditions
Dr. Richard K. Valicenti
Radiology | Radiation Oncology
Expertise in
5
conditions
Dr. Richard K. Valicenti
Radiology | Radiation Oncology
Referral may be required
Before you request

Mercy Cancer Center

3850 G St, 
Merced, CA 
 (2.5 miles away)
209-564-3600
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Richard Valicenti is a Radiologist and a Radiation Oncologist practicing medicine in Merced, California. Dr. Valicenti is highly rated in 5 conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Muscle Invasive Bladder Cancer, Cervical Cancer, and Prostatectomy. Dr. Valicenti is board certified in Radiology Radiation Oncology. Dr. Valicenti is currently accepting new patients.

Frequently Asked Questions about Dr. Arta M. Monjazeb

How do I make an appointment with Dr. Arta M. Monjazeb?

You can book an appointment with Dr. Arta M. Monjazeb by calling their office at 209-564-3600. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Arta M. Monjazeb a top-rated expert for Adult Soft Tissue Sarcoma?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Arta M. Monjazeb is classified as an Elite expert for Adult Soft Tissue Sarcoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Arta M. Monjazeb specialize in?

While Dr. Arta M. Monjazeb is a Radiology, they have specific expertise in Adult Soft Tissue Sarcoma, Bone Tumor, and Squamous Cell Carcinoma of the Anal Canal (SCAC). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Radiology.

Does Dr. Arta M. Monjazeb participate in research or clinical trials?

Yes. Dr. Arta M. Monjazeb has published 111 articles and abstracts on conditions like Adult Soft Tissue Sarcoma. You can view a list of Dr. Arta M. Monjazeb's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Arta M. Monjazeb accept my insurance?

Dr. Arta M. Monjazeb accepts most major insurance plans, including Anthem BCBS and Blue Shield of California. We recommend calling the office directly at 209-564-3600 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Monjazeb's expertise for a condition
ConditionClose
View All 14 Advanced Conditions
View All 56 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile